OphthoTech Corp: Annual Report 2015 (IVERIC bio) - Mar 5, 2016 - Anticipated expiry of patents in US and under the PCT covering dosing regimens, methods of treating AMD and other proprietary technology in 2035; Anticipated expiry of composition of matter patent in US in 2017; Anticipated expiry of composition of matter patent in EU, Japan, and ROW in 2018
Anticipated patent expiry • Age-related Macular Degeneration • Ophthalmology
|